Back

Unraveling immune checkpoint inhibitors effects on atherosclerosis: mechanisms and preventive approaches

30 August 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology in practice Cardio-Oncology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Inbar Nardi Agmon

Chaim Sheba Medical Center, Tel Aviv Universty, Ramat Gan (Israel)

2 More presentations in this session

Presentation thumbnail
Cardiovascular events in CML patients treated with nilotinib: validation of the HFA-ICOS baseline risk score
Doctor M. Andres (London, GB)
Abstract Slides Video
Presentation thumbnail
The safety of standardized management of suspected cardiovascular immune-related events in patients treated by immunecheckpoints inhibitors
Doctor F. Cribari (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-oncology in practice
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Case 3: late cardiovascular toxicity during immune checkpoint inhibitors therapy
thumbnail
Congress Session
Cardio-oncology in practice
thumbnail
Congress Presentation
Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources